You are here

Gilead questions WHO study that cast doubts on drug's Covid-19 benefits

rk_Remdesivir_161020.jpg
Gilead Sciences has questioned the findings of a World Health Organization (WHO) study that concluded its Covid-19 drug remdesivir does not help patients who have been admitted to hospital.

[SWITZERLAND] Gilead Sciences has questioned the findings of a World Health Organization (WHO) study that concluded its Covid-19 drug remdesivir does not help patients who have been admitted to hospital.

The American company told Reuters the data appeared inconsistent, the findings were...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes